Indian Army Department Of Military Affairs Tender for Glycopyrrolate, Formoterol Fumarate & Budesonide Inhalation, Sunscreen Lotion Bottles, and Related Tablets 2026

Tender Overview

• The procuring organization is the Indian Army under the Department Of Military Affairs. The tender covers a mix of pharmaceutical products and a sunscreen lotion bottle, spanning inhalation drugs, tablets, and topical formulations. The estimated contract value is ₹99,702, with a total of 5 items in the BOQ. No start/end dates or explicit location are provided, but the scope centers on supplying listed pharmaceutical and cosmetic items to military medical channels. A notable differentiator is the inclusion of specialized inhalation therapy combinations and sun protection formulations, indicating a priority on medically vetted, patient-ready products. The listing suggests a consolidated supply requirement rather than a segmented, site-specific rollout.

Technical Specifications & Requirements

• No detailed technical specifications are published in the tender text. Items referenced include:
  • Glycopyrrolate, Formoterol Fumarate, Budesonide in inhalation form
  • Acebrophylline 100mg with Acetylcysteine 600mg tablet
  • Zinc Oxide-Titanium Dioxide-based sunscreen lotion, 60 ml bottle, SPF 50
  • Rebamipide 100mg tablet
  • Faropenem 200mg tablet
• The BOQ shows 5 items but lists N/A for quantity and unit, implying unfinalized scope or placeholder entries. The tender emphasizes service/support readiness, including a dedicated toll-free service line for bidders/OEMs, signaling post-award support expectations. The absence of explicit IS/ISO or brand requirements means bidders should prepare general GMP/compliance documentation and OEM authorizations where applicable.

Terms, Conditions & Eligibility

• EMD is not clearly specified in the provided data; bidders should verify exact amount in the official portal.
• A dedicated toll-free service line is mandated for service support (from bidder or OEM).
• The tender requires submission of standard bid documents (GST, PAN, experience evidence, financials, EMD documentation, OEM authorizations) per typical government pharmacopeia procurement norms.
• The 5-item BOQ indicates a broad product mix; bidders must confirm exact quantities and packaging configurations with the procuring authority prior to submission.
• Registration with relevant drug regulatory authorities and compliance with applicable pharmaceutical standards is recommended to secure eligibility.